What is Toothsi?
Toothsi operates at the intersection of healthcare and consumer technology, providing a sophisticated, at-home alternative to traditional orthodontic treatments. By utilizing clear aligners manufactured from high-grade, BPA-free, and FDA-approved materials, the company offers a scientifically validated solution for teeth straightening that is significantly more accessible than conventional braces. Its market position is defined by a commitment to affordability and convenience, effectively disrupting the traditional dental care model through a digital-first, patient-centric platform. The company's core value proposition centers on democratizing access to aesthetic dental care, ensuring that high-quality orthodontic services are available outside of clinical settings.
How much funding has Toothsi raised?
Toothsi has raised a total of $74M across 4 funding rounds:
Series A
$5M
Series B
$20M
Unspecified
$9M
Series C
$40M
Series A (2021): $5M with participation from Think Investments
Series B (2021): $20M led by Mankekar Family Office, Eight Roads, and Think Investments
Unspecified (2022): $9M supported by Stride Ventures
Series C (2022): $40M featuring IIFL, Paramark, and Eight Roads
Key Investors in Toothsi
Eight Roads
Eight Roads is a global venture capital firm headquartered in Kent, specializing in providing growth capital to businesses across the real estate, venture, and technology sectors.
Stride Ventures
Based in New Delhi, Stride Ventures is a prominent venture capital firm focused on identifying and supporting innovative, high-growth startups within the Indian market.
Think Investments
Think Investments is an institutional investment firm that provides strategic financial backing to companies demonstrating significant potential for market disruption and long-term scalability.
What's next for Toothsi?
With the successful closure of its latest funding round, Toothsi is well-positioned to enhance its technological capabilities and expand its geographic footprint. The strategic focus will likely shift toward optimizing supply chain efficiencies and deepening its penetration in the dental-tech ecosystem. By prioritizing research and development, the company aims to refine its aligner technology while maintaining its competitive edge in the direct-to-consumer space. As the firm scales, it will likely explore further integration of digital diagnostics and personalized treatment planning, ensuring that its service delivery remains at the forefront of the industry. The continued support from institutional backers provides the necessary runway to navigate future market challenges and sustain long-term growth in the evolving health-tech landscape.
See full Toothsi company page
